Date created: | Last Updated:

Category: Project

Description: Obesity and associated diseases such as type 2 diabetes are one of the leading causes of death and public expenditure worldwide. Early detection of these diseases before symptoms arise may enable effective prevention and intervention thus turning the tide against these diseases. Current genetic biomarkers have low power to predict the onset of lifestyle-related disease such as obesity and type-2 diabetes as they cannot account for environmental factors, which play a major role in the development of these conditions. The overall goal of OBEDIA-MARK is to advance the field of precision medicine for obesity-associated diseases such as type-2 diabetes by identifying biomarkers and individual characteristics that enable early detection and personalized intervention. This project was supported by the European Union’s Horizon 2020 Research and Innovation Programme (grant/award number 701944)